Folic acid/oral contraceptives

29 Sep 2003
News

Executive Summary

FDA's Reproductive Health Drugs Advisory Committee will discuss the potential benefits of combining folic acid and oral contraceptives into a single product at a Dec. 15 meeting. Oral contraceptives are known to reduce the levels of folic acid, and reduced folic acid levels have been associated with neural tube defects in newborns. The meeting will be held at the Hilton in Gaithersburg, Md. beginning at 8 a.m...

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS042534

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS042534

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Folic acid/oral contraceptives

News

Executive Summary

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert